This is the first edition of “Biotech & Pharma Stock Market Recap” - welcome welcome!

What’s to be covered in this hallowed scroll:

1. Overview of the biotech & pharma stocks that had the best & worst weeks (as measured by % change in price)

2. We’ll give you a calendar of whose announcing earnings in the upcoming week - and if they’re before the markets open (BMO) or after markets close (AMC).

3. One more thing we’ll have in future weeks - a recap of the more notable earnings calls the week previous.

Lastly - all three of the above will have sub-sections divided by:

1. Biotechnology (life sciences and the like)

2. Drug Manufacturers - General (this one includes big pharma)

3. Drug Manufacturers - Specialty and Pharma (everyone else that makes drugs, and then some)

And last thing - everything is in USD unless otherwise stated!

This weekend edition is a new feature at TLDR Biotech, so I’d love to get your feedback.

(You can also reach out to me on LinkedIn)

ENJOYING THESE NEWSLETTERS?
Consider an optional paid subscription.

TLDR Biotech is currently a one-person show that works full-time to put together these compilations and related content.

If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.

Biotechnology

For some, a 40%+ weekly jump isn’t enough to make up for YTD losses.

Upcoming Biotechnology Earnings Calls

In related but not entirely related news, the founder and former CEO of Roivant made some interesting (surprising?) stock investments this week.

Drug Manufacturers - General

Condolences to anyone owning Pfizer shares - at least it’s not in the red! And praying for another MIRAculous week for MIRA.

Upcoming Drug Manufacturers - General Earnings Calls

No earnings next week for this group!

Drug Manufacturers - Specialty & Generic

It ain’t all sunshine for Sunshine BioPharma - but if you own DURECT, you’re probably laughing DURECTly to the bank with those gains.

Upcoming Drug Manufacturers - Specialty & Generic Earnings Calls

I guess 🌲 counts as a “Specialty” drug manufacturer?

Join us next week for another biotech & pharma stock market round-up - now go enjoy your weekend!

TLDR Biotech wants to hear from you! 📣 

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

And if you like this newsletter and think a friend or colleague would benefit, please share this with them! ♻️

Want to sponsor this newsletter and reach an audience of 100+ biotech and pharma professionals? Reach us here. 👍

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here